FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 36 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $118 | -99.8% | 12,245 | +69.0% | 0.00% | +50.0% |
| Q3 2022 | $59,000 | +78.8% | 7,245 | +20.8% | 0.00% | +100.0% |
| Q2 2022 | $33,000 | -2.9% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $34,000 | +30.8% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $26,000 | -54.4% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $57,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
| Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
| DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
| AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
| Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
| Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
| 683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |